Clinical Research Informer

Grand Rounds May 12, 2023: Design and Pragmatic Trial of COACH: A Patient Portal/EHR Information System for Home Blood Pressure Monitoring in Hypertension (Richelle J. Koopman, MD, MS)

Rethinking Clinical Trials

MAY 19, 2023

Colwill Professor and Vice Chair Department of Family and Community Medicine University of Missouri Slides Keywords Electronic Health Record, Pragmatic Clinical Trial Key Points Patients bring patient-generated home blood pressure data into the clinical workflow. Koopman, MD, MS Jack M. and Winifred S. There is billing potential here.

Trials

Trials Clinical Trials Clinical Trials Medicine

Grand Rounds January 26, 2024: Advancing the Safe, Effective and Equitable Use of AI in Healthcare (Mark Sendak, MD, MPP; Suresh Balu, MD, MBA)

Rethinking Clinical Trials

JANUARY 31, 2024

Frontline staff have to have buy-in to submit a proposal so organizational resources can be used to sustain the innovation. The first key decision point is procurement, which begins with identifying a problem and ends with allocation of resources to either build or buy an AI product or solution. Key decision point 1 is procurement.

Production

Production Development Clinical Trials Clinical Trials

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Rethinking Clinical Trials

MARCH 6, 2024

Schell Professor of Management and Applied Economics MIT Sloan School of Management Slides Keywords Food-as-Medicine, Randomized Clinical Trial, Diabetes Key Points Diabetes is common and costly. Payers should have some incentive to improve outcomes because sustained reduction in HbA1c from poor to fair can result in cost savings.

Clinical Trials

Clinical Trials Clinical Trials Medicine Trials

Grand Rounds July 14, 2023: Lessons From the COORDINATE-Diabetes Trial (Christopher B. Granger, MD; Neha J. Pagidipati, MD, MPH)

Rethinking Clinical Trials

JULY 19, 2023

How can you sustain this intervention across all components of the process? That might be an important jumping point for the second leg of COORDINATE-Diabetes to answer questions such as: How do you get payers and Medicare to sustain these interventions? Distinguished Professor of Medicine Professor of Nursing Duke University Neha J.

Trials

Trials Cardiology Medicine Nurses

Grand Rounds September 15, 2023: Effect of Financial Incentives and Default Options on Food Choices of Adults With Low Income in Online Retail Settings (Pasquale Rummo, PhD, MPH)

Rethinking Clinical Trials

SEPTEMBER 21, 2023

I want to acknowledge that there’s definitely questions about the sustainability of types of behavior changes like the default options or even the economic incentives. I’m a little less interested in the sustainability of those effects. My thoughts differ for each strategy.

Clinical Trials

Clinical Trials Clinical Trials Sales Trials

Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? (Margaret Kuklinski, PhD; Stacy Sterling, DrPH, MSW)

Rethinking Clinical Trials

JULY 14, 2023

Tyson School of Medicine Slides Keywords Pragmatic Clinical Trial, GGC4H, Prevention Key Points Guiding Good Choices for Health Study (GGC4H) is about the Guiding Good Choices (GGC) intervention, a group-based program for parents and caregivers of younger adolescents (ages 9-14).

Clinical Trials

Clinical Trials Clinical Trials Trials Research

Grand Rounds June 16, 2023: BeatPain Utah: Partnering With Community Health Centers Within a Socio-Technical Framework (Julie Fritz, PT, PhD, FAPTA; Guilherme Del Fiol, MD, PhD)

Rethinking Clinical Trials

JULY 9, 2023

Researchers must also be prepared to consider the question of sustaining a service that many clinics in the study have come to rely on, even before the results are available.

Clinical Trials

Clinical Trials Clinical Trials Trials Research

Grand Rounds June 30, 2023: Decentralized Trials – From Guidance to Reality & What’s Left (Adrian Hernandez, MD, MHS; Pamela Tenaerts, MD, MPH; Craig Lipset, MPH)

Rethinking Clinical Trials

JULY 6, 2023

This guidance and others in development in other markets act as an important countermeasure to ensuring sustained adoption and implementation of DCTs. The Food and Drug Administration (FDA) issued a draft guidance in May 2023 that provided guidance about the conduct of decentralized clinical trials.

Trials

Trials Clinical Trials Clinical Trials Licensing

Grand Rounds June 2, 2023: PROACT Xa and The Wizard of Oz: Behind the Curtain of a Pragmatic Decentralized Clinical Trial (John Alexander, MD, MHS)

Rethinking Clinical Trials

JUNE 7, 2023

The pragmatic elements were already in place so when COVID happened the main thing that had the biggest impact on our study was the shortage of study coordinators that effected every trial, and a few of our study sites went under due to difficulty of staffing and sustaining a research enterprise. We never had an amendment to the protocol.

Clinical Trials

Clinical Trials Clinical Trials Trials Cardiology

Life Science Marketers: How to Connect Content to B2B Revenue Growth

XTalks

JUNE 26, 2023

By targeting relevant keywords and addressing industry-specific topics, businesses can attract organic traffic to their website, increase brand visibility and generate leads that are actively searching for their products or services. Consistently delivering high-quality content that meets the needs of their target audience is crucial.

Life Science

Life Science Marketing Sales Production

3 Reasons Why a Talent Community is Valuable for Life Science Recruitment

XTalks

JANUARY 5, 2022

The talent community is sustainable. Some of the features include our job category search with optimized keyword search, which helps the best candidates find your job posting faster. Employers are consistently building profiles for candidates they need to hire. Job seekers are browsing or searching for different careers/jobs.

Life Science

Life Science Branding Regulation Production

What CX Tech Innovations Options Are Ripe for Consideration?

pharmaphorum

MARCH 18, 2021

The text can then be scanned and analysed for keywords. Exeevo is a unified, intelligent and agile digital ecosystem for life sciences organisations to revolutionise health experiences for healthcare teams and patients in their journey towards sustainable health outcomes. The technology is relatively mature now.

Sales

Sales Pharma Companies Engineer Life Science

Grand Rounds August 11, 2023: The REMAP-CAP Adaptive Platform Trial: Recent Insights and Future Directions (Patrick Lawler, MD, MPH)

Rethinking Clinical Trials

OCTOBER 24, 2023

REMAP-CAP is an adaptive platform trial simultaneously evaluation multiple treatments in domains using a master protocol. In adaptive trials, trial design features are modified during the trial to maximize statistical efficiency or achieve better patient outcomes.

Trials

Trials Clinical Trials Clinical Trials Cardiology

Grand Rounds July 21, 2023: Implementing New Care Pathways for Low Back Pain in Academic Healthcare Systems: Early Lessons from IMPACt-LBP (Christine Goertz, DC, PhD; Adam Goode, DPT, PhD)

Rethinking Clinical Trials

AUGUST 28, 2023

– Do you think that this intervention is sustainable? We do have some sub-group analyses plans for the trial, not specific to imaging, but it is something we could consider. Inappropriate early imaging is included in our outcome measures, but we could consider some deeper work and analyses.

Trials

Trials Research Medicine Doctors

Grand Rounds August 5, 2022: Economic Evaluation of Platform Trial Designs (Jay JH Park, PhD, MSc)

Rethinking Clinical Trials

AUGUST 11, 2022

These platform trials are almost a public good so that there is a sustainable model for the infrastructure so it continues to grow and evolve and no one bears the full cost. ?. Speaker. Jay JH Park, PhD, MSc. Assistant Professor. Department of Health Research Methods, Evidence and Impact. Faculty of Health Sciences. McMaster University.

Trials

Trials Clinical Trials Clinical Trials Research

Clinical Research Informer

Grand Rounds May 12, 2023: Design and Pragmatic Trial of COACH: A Patient Portal/EHR Information System for Home Blood Pressure Monitoring in Hypertension (Richelle J. Koopman, MD, MS)

Grand Rounds January 26, 2024: Advancing the Safe, Effective and Equitable Use of AI in Healthcare (Mark Sendak, MD, MPP; Suresh Balu, MD, MBA)

Trending Sources

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Grand Rounds July 14, 2023: Lessons From the COORDINATE-Diabetes Trial (Christopher B. Granger, MD; Neha J. Pagidipati, MD, MPH)

Grand Rounds September 15, 2023: Effect of Financial Incentives and Default Options on Food Choices of Adults With Low Income in Online Retail Settings (Pasquale Rummo, PhD, MPH)

Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? (Margaret Kuklinski, PhD; Stacy Sterling, DrPH, MSW)

Grand Rounds June 16, 2023: BeatPain Utah: Partnering With Community Health Centers Within a Socio-Technical Framework (Julie Fritz, PT, PhD, FAPTA; Guilherme Del Fiol, MD, PhD)

Grand Rounds June 30, 2023: Decentralized Trials – From Guidance to Reality & What’s Left (Adrian Hernandez, MD, MHS; Pamela Tenaerts, MD, MPH; Craig Lipset, MPH)

Grand Rounds June 2, 2023: PROACT Xa and The Wizard of Oz: Behind the Curtain of a Pragmatic Decentralized Clinical Trial (John Alexander, MD, MHS)

Life Science Marketers: How to Connect Content to B2B Revenue Growth

3 Reasons Why a Talent Community is Valuable for Life Science Recruitment

What CX Tech Innovations Options Are Ripe for Consideration?

Grand Rounds August 11, 2023: The REMAP-CAP Adaptive Platform Trial: Recent Insights and Future Directions (Patrick Lawler, MD, MPH)

Grand Rounds July 21, 2023: Implementing New Care Pathways for Low Back Pain in Academic Healthcare Systems: Early Lessons from IMPACt-LBP (Christine Goertz, DC, PhD; Adam Goode, DPT, PhD)

Grand Rounds August 5, 2022: Economic Evaluation of Platform Trial Designs (Jay JH Park, PhD, MSc)

Stay Connected